Titanium substrata composition influences osteoblastic phenotype: In vitro study

Journal of Biomedical Materials Research

Volumn 47, Issue 3, 1999, Pages 360-366

  Zreiqat, Hala ^a   Howlett, C Rolfe ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Osteoblast like cells; Osteogenic proteins; Titanium; Titanium alloy

Indexed keywords

ALKALINE PHOSPHATASE; BIOMATERIAL; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; SIALOPROTEIN; THROMBOSPONDIN; TITANIUM;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; OSTEOBLAST; PHENOTYPE; RNA TRANSLATION; SURFACE PROPERTY;

ADOLESCENT; ALKALINE PHOSPHATASE; ALLOYS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; CELLS, CULTURED; COLLAGEN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IN SITU HYBRIDIZATION; OSTEOBLASTS; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SIALOGLYCOPROTEINS; THROMBOSPONDINS; TITANIUM; TRANSCRIPTION, GENETIC;

EID: 0033527922     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K     Document Type: Article

References (48)

1. Kasemo B, Lausamaa J. Biomaterial and implant surfaces: a surface science approach. Int J Oral Maxillofac Implants 1988; 3:247-259.
2. Williams DF. titanium and titanium implants. In: Williams DF, editor. Biocompatibility of clinical implant biomaterials. Boca Raton, FL: CRC Press; 1981.
3. Hanawa T. Titanium and its oxide film: a substrate for formation of apatite. In: Davies JE, editor. The bone biomaterial interface. Volume 4. Toronto: University of Toronto Press; 1991. p 49-61.
4. Balkin BE. Implant dentistry: historical overview with current perspective [Review]. J Dent Ed 1988;52:683-685.
5. Williams DF. Implants in dental and maxillofacial surgery [Review]. Biomaterials 1981;2:133-146.
6. Imam MA, Fraker AC. Titanium alloys as implant materials. In: Brown SA, Lemons JE, editors. Medical applications of titanium and its alloys. Philadelphia, PA: American Society for Testing and Materials; 1996. p 3-16.
7. Dobbs HS, Scales JT. Behavior of commercially pure titanium and Ti alloy (Ti-6Al-4V) in orthopaedic implants. In: Luckey HA, Kubli F Jr, editors. Titanium alloys in surgical implants. ASTM STP 796. Philadelphia, PA: American Society for Testing and Materials; 1983. p 174-186.
8. Bannon BP, Mild EE. Titanium alloys for biomaterial application: an overview. In: Luckey HA, Kubli F Jr, editors. Titanium alloys in surgical implants. ASTM STP 796. Philadelphia, PA: American Society for Testing and Materials; 1983. p 7-15.
9. Keller JC, Lautenschlager EP. Metals and alloys. In: Von Recum A, editor. Handbook of biomaterials evaluation. New York: Macmillan; 1986. p 3-24.
10. Johansson C, Lausmaa J, Ask M, Hansson HA, Albrektsson T. Ultrastructural differences of the interface zone between bone and Ti-6Al-4V of commercially pure Ti. J Biomed Eng 1989;11: 3-8.
11. Davies JE, Lowenberg B, Shiga A. The bone titanium interface in vitro. J Biomed Mater Res 1990;24;1289-1306.
12. Lowenberg B, Chernecjy R, Shiga A, Davies JE. Mineralized matrix production by osteoblasts on solid titanium in vitro. Cells Mater 1991;1:177-187.
13. Orr RD, DeBrujin JD, Davies JE. Scanning electron microscopy of the bone interface with titanium, titanium alloy and hydroxyapatite. Cells Mater 1992;2:241-245.
14. Bellows CG, Aubin JE, Heersche JNM, Antosa ME. Mineralized nodules formed in vitro from enzymatically released rat calvaria populations. Calcif Tissue Int 1986;38:143-154.
15. Howlett CR, Zreiqat H, Odel R, Noorman J, Evans P, Dalton BA, McFarland C, Steele JG. The effect of magnesium ion implantation into alumina upon the adhesion of human bone-derived cells. J Mater Sci Mater Med 1994;5:715-722.
16. Zreiqat H, Markovic B, Walsh WR, Howlett CR. A novel technique for quantitative detection of mRNA expression in human bone derived cells cultured on biomaterials. J Biomed Mater Res Appl Biomater 1996;33:217-223.
17. Markovic B, Wu Z, Chesterman CN, Chong BH. Quantitation of FcgRII mRNA in platelets and megakaryoblastic cell lines by a new method of in situ hybridization. J Immunol Methods 1994;172;105-114.
18. Zreiqat H, Sungaran S, Howlett CR, Markovic B. Quantitative aspects of an in situ hybridization procedure for detecting mRNAs in cells using 96 well microplates. Mol Biotechnol 1998;10:107-113.
19. Albrektsson B, Branemark PI, Hansson HA, Lindstrom J. Osseointegrated titanium implants, requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981;52:155-170.
20. Puleo DA, Preston K, Shaffer J, Bizios R. Examination of osteoblast-orthopaedic biomaterial interactions using molecular technique. Biomaterials 1993;14;111-114.
21. Zou L, Walsh WR, Keeping H, Howlett CR, Steele JG, McFarland C, Russel M, Ehrlich M. Osteoblast orthopaedic biomaterial response. In: Mikos AG, Murphy MR, Bernstein H, Peppas NA, editors. Osteoblast-orthopaedic biomaterial response. Volume 331: Biomaterials for drug and cell delivery. Philadelphia, PA: Materials Research Society; 1994. p 127-131.
22. Zreiqat H, Evans P, Howlett CR. The effect of surface chemical modification of bioceramic on the phenotype of human bone-derived cells. J Biomed Mater Res 1999;44:389-396.
23. Zreiqat H, McFarland C, Howlett CR. The effect of polymeric surface chemistry on the expression of bone-related genes and proteins by human bone-derived cells in vitro. J Biomater Sci Polym Ed 1999;10:199-216.
24. Howlett CR, Evans MDM, Wildish KL, Kelly JC, Fisher LR, Francis BW, Best JD. The effect of ion implantation on cellular adhesion. Clin Mater 1993;14:57-64.
25. Zreiqat H, Standard OC, Gengenbach T, Steele J, Howlett CR. The role of surface characteristics in the initial adhesion of human bone-derived cells on ceramics. Cells Mater 1996;6:45-56.
26. Howlett CR, Zreiqat H, Wu Y, McFall DW, McKenzie DF. The effect of ion modification of commonly used orthopaedic materials on the attachment of human bone-derived cells. J Biomed Mater Res 1999;45:345-354.
27. Hambleton J, Schwartz Z, Khare A, Windeler SW, Luna M, Brooks BP, Dean DD, Boyan BD. Culture surfaces coated with various implant materials affect chondrocyte growth and metabolism. J Bone Joint Surg 1993;12:542-552.
28. Schwartz Z, Boyan BD. Underlying mechanisms at the bone-biomaterial interface. J Cell Biochem 1994;56:340-347.
29. Bellows CG, Aubin JE, Heersche JNM, Antosa ME. Mineralized nodules formed in vitro from enzymatically released rat calvaria populations. Calcif Tissue Int 1986;38:143-154.
30. Groessner-Schreiber B, Tuan RS. Enhanced extracellular matrix production and mineralization by osteoblasts cultured on titanium surfaces in vitro. J Cell Sci 1992;101:209-217.
31. Aubin JE, Liu F, Malaval L, Gupta AK. Osteoblast and chondroblast differentiation. Bone 1995;2:77S-83S.
32. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue specific gene expression during osteoblast differentiation. FASEB J 1990;4:3111-3123.
33. Askeland DR. Ceramic materials. In: Askeland DR, editor. The science and engineering of materials. London: Chapman & Hall; 1990. p 447-455.
34. Gerber H, Perren SM. Evaluation of tissue compatibility of in vitro cultures of embryonic bone. In: Winter GD, Leray JL, deGroot K, editors. Evaluation of biomaterials. New York: Wiley; 1980. p 307-314.
35. Blumenthal NC, Cosma V. Inhibition of apatite formation by titanium and vanadium ions. J Biomed Mater Res 1989;23;13-22.
36. Flessel CP. Metals as mutagenic initiators of cancer. In: Kharasch N, editor. Trace metals in health and disease. New York: Raven; 1979. p 109.
37. Evans EJ, Thomas IT. The in vitro toxicity of cobalt-chrome-molybdenum alloy and its constituent metals. Biomaterials 1986;7;25-29.
38. Laing PG, Fergoson AB Jr, Hodge ES. Tissue reaction in rabbit muscle exposed to metallic implants. J Biomed Mater Res 1967;1;135-149.
39. Agnis HJ, Alcock NW, Bansal M, Salvati EA, Willson PD, Pellicci PM, Bullough PG. Metallic wear in failed titanium-alloy total hip replacement. J Bone Joint Surg 1988;70A:347-356.
40. Martin JY, Schwartz Z, Hummert TW, Schraub DM, Simpson J, Lankford J, Dean DD, Cochran DL, Boyan BD. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 1995;29:389-401.
41. Clark GCF, Williams DF. The effect of proteins on metallic corrosion. J Biomed Mater Res 1982;16:125-134.
42. Underwood PA, Steele JG, Dalton BA. Effects of polystyrene surface chemistry on the biological activity of solid phase fibronectin and vitronectin, analysed with monoclonal antibodies. J Cell Sci 1993;104:793-803.
43. Herring GM. The organic matrix of bone. In: Bourne GH, editor. The biochemistry and physiology of bone. Volume 1. New York: Academic Press; 1972. p 127-189.
44. Franzen A, Heinegard D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 1985;232:715-724.
45. Kasugai S, Todescan R, Nagata T, Yao KL, Butler W, Sodek J. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype. J Cell Physiol 1991;147;111-120.
46. Nagata T, Bellows CG, Kasugai S, Butler WT, Sodek J. Biosynthesis of bone proteins (SPP-1 [secreted phosphoprotein-1, osteopontin], BSP (bone sialoprotein) and SPARC (osteonectin)) in association with mineralized-tissue formation by foetal-rat calvarial cell culture. Biochem J 1991;274:513-520.
47. Ibaraki K, Termine JD, Whitson W, Young MF. Bone matrix mRNA expression in differentiating foetal bovine osteoblasts. J Bone Miner Res 1992;7:743-754.
48. Keller JC, Stanford CM, Draughn RA, Wightman JP. In vitro responses to cpTi and Ti-6Al-4V alloy. In: Brown SA, Lemons JE, editors. Medical applications of titanium and its alloys. Philadelphia, PA: American Society for Testing and Materials; 1996. p 319-331.